Biotechnology · Healthcare
Chief Accounting Officer, CFO
2026-08-03–present
Chief Accounting Officer
Vir Biotechnology, Inc. (VIR)Equibles does not estimate personal net worth.
Get an email with a short summary when Vir Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get VIR alertsBrent Sabatini is recorded as CFO at Vir Biotechnology, Inc. (VIR) since August 3, 2026 and Chief Accounting Officer at Vir Biotechnology, Inc. (VIR). Brent Sabatini has spoken on 1 earnings call across 1 company, most recently for Vir Biotechnology, Inc. on August 5, 2026. Vir Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vir Biotechnology, Inc. includes Marianne De Backer, MSc, Ph.D., MBA (CEO and Board Member), Aziz Sawaf (CFO), Howard Horn (CFO) and 7 others.
“I am pleased to share that we saw significant improvement in our cash position over the second quarter of 2026. We ended the quarter with approximately $1.01 billion in cash, cash equivalents and investments, representing an increase of $198.5 million.”
2026-08-03–present
Biotechnology · Healthcare
Chief Accounting Officer, CFO
2026-08-03–present